Clinical Trials Logo

Clinical Trial Summary

This is a single-arm longitudinal group to examine patient-reported outcomes, body mass and mammographic density changes pre- and post- weight loss intervention of breast cancer survivors using video conferencing telehealth visits.


Clinical Trial Description

Participants will receive weekly group sessions of lifestyle counseling for the first 20 weeks, followed by every other week sessions in weeks 22 and 24, for a total of 6 months of intervention. These group sessions, with 6 participants per group, will be delivered virtually via a HIPAA Compliant Teleconference Platform. The expected number of participants is at least 2 and no more than 6 in this 90-min group sessions which will be provided by a counselor from Penn Center for Weight and Eating Disorders. The content of the sessions addresses the domains associated with behavioral weight management, including nutrition, exercise, stress and emotion management, and lifestyle modification strategies (to improve adherence to the diet and activity plan). Participants will monitor energy intake and physical activity daily to help them achieve recommended calorie and activity goals. Self-monitoring will be encouraged online with MyFitnessPal.com, which will be shared with the study staff to increase accountability and provide opportunity for feedback to participants. Each participant will also be mailed a digital scale so they can weigh themselves each week and report their weight to the group leader. Participants will be encouraged to start with at least 10 minutes of moderately vigorous physical activity (e.g., brisk walking, swimming), at least five days per week, building up to at least 30 minutes per day (150 minutes per week) by week 6. The primary objective is to assess feasibility and acceptance of telehealth weight loss intervention by the participants. The participants will be asked to complete the following surveys at two time points: baseline (pre-) and treatment end (at week 24). The participants will complete the following psychosocial measures. 1. City of Hope Quality of Life (COH-QOL) Instrument - Breast Cancer Patient (QOL-BC) 2. The International Physical Activity Questionnaire (IPAQ) Short Form - that assess the types and intensity of physical activity and sitting time in which people routinely engage. It provides an estimate of total physical activity in MET-min/week and time spent sitting. 3. Patient Health Questionnaire (PHQ-9) (Depression) 4. Acceptability of Intervention Measure Finally, investigators will conduct an exit interview with each participant to assess the acceptability of the intervention, the delivery of the intervention via telehealth, and the patients' satisfaction with their treatment outcomes. Investigators will also solicit suggestions for improvements to the program for future interventions. The secondary objectives are to measure changes from pre- to post weight-loss intervention for 1) body mass and 2) mammographic breast density. To assess body mass changes, weight will be reported at baseline and after week 24 of the intervention. The scale will be mailed to participants at the beginning of the study. Participants' height from the electronic medical record will be used. Percent weight loss will be calculated to assess weight change across participants. To assess mammographic breast density changes, investigators will measure mammographic density of annual mammogram pre- and post weight-loss program. Annual mammograms are routinely performed for breast cancer survivors except for those who have had bilateral mastectomy. Two annual mammograms will be used to measure mammographic density. The annual mammogram performed between 1 month - 12 months prior to weight loss program initiation will be used as baseline (pre-intervention). The post-intervention mammogram will be the first annual mammogram performed after weight loss program. If routine annual mammogram occurs during the 20-week weight loss program, then the next annual mammogram will be used for breast density assessment. Therefore, study duration for each participant from enrollment to completion (mammographic density) is estimated to be up to 24 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04855552
Study type Interventional
Source Abramson Cancer Center of the University of Pennsylvania
Contact Julia C Tchou, MD, PhD
Phone (215) 615-7575
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date May 2021
Completion date December 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices N/A
Recruiting NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Recruiting NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Recruiting NCT04511325 - Effects of White Potato Consumption on Measures of Cardiometabolic Health in Individuals With Type 2 Diabetes Mellitus N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Recruiting NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Recruiting NCT04795973 - Efficacy of Intermittent Fasting on Weight Loss and Related Metabolic Parameters in Adults With Overweight or Obesity N/A
Not yet recruiting NCT04561284 - Carbohydrate-induced Resilience of the Gut Microbiome After Antibiotics Use N/A
Not yet recruiting NCT04184479 - Effect of the LEVAmethod by Bertz et al © in Subjects With Overweight or Obesity in Primary Health Care. N/A
Completed NCT03055416 - Mobile Phone Intervention for Physical Activity Maintenance in African American Men (MobileMen) N/A
Completed NCT02924025 - Motivational Interviewing as an Intervention for PCOS N/A
Completed NCT02196012 - A Technology-Based Intervention for the Reduction of Overweight and Obesity Among College Students N/A
Completed NCT02456623 - Obesity Intervention for Low-Income African American Preschoolers N/A
Completed NCT01717352 - Sleep Plus Eating Routines for Weight Loss Phase 2